Research
Phosphatidic Acid (PA)
4 peer-reviewed studies curated from PubMed and Semantic Scholar.
Studies
Sorted by quality and recency
Effects of phosphatidic acid supplementation on muscle thickness and strength in resistance-trained men.
RCT investigating the effects of phosphatidic acid supplementation on muscle thickness and strength in 15 resistance-trained men over 8 weeks. No significant differences were found between the phosphatidic acid and placebo groups in muscle thickness or strength gains, although all participants improved overall.
The effects of phosphatidic acid supplementation on strength, body composition, muscular endurance, power, agility, and vertical jump in resistance trained men.
RCT of 18 strength-trained males comparing MaxxTOR (containing phosphatidic acid) to placebo over eight weeks. MaxxTOR significantly increased lean body mass and strength (leg press and bench press) compared to placebo, with no significant differences in fat mass, thigh muscle mass, vertical jump, agility, power, or push-ups.
Phytic acid concentration influences iron bioavailability from biofortified beans in Rwandese women with low iron status.
RCT measuring iron absorption in 22 Rwandese women consuming meals with biofortified beans with varying phytic acid concentrations. High phytic acid concentrations decreased iron bioavailability, suggesting that reducing phytic acid could enhance the effectiveness of iron biofortification in beans.
Pharmacokinetics of Panaxynol in Mice
The study explores the pharmacokinetic parameters of panaxynol (PA) in mice, using both in vitro and in vivo methods. PA was administered to CD-1 mice via intravenous injection or oral administration, and concentrations were measured using LC-MS/MS. The study found that PA has a half-life of 1.5 hours when IV-injected and 5.9 hours when administered orally, with a moderate bioavailability of 50.4%. No toxicity was observed in mice up to 300 mg/kg orally.